Skip to content

Using Mindfulness-Based Cognitive Therapy to Prevent Suicide among High Suicide Risk Patients who also Misuse Opioids: A Preliminary Probe of Feasibility and Effectiveness.

Megan S Chesin, Chintan V Dave, Catherine E Myers, Barbara Stanley, Anna Kline, Maureen Monahan, Miriam Latorre, Lauren M Hill, Rachael B Miller, Arlene King, Dianna R. Boschulte, Megan M Sedita, Alejandro Interian

International Journal of Mental Health and Addiction April 1, 2022 DOI: 10.1007/s11469-022-00817-x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Secondary analysis of a randomized clinical trial Peer reviewed
Sample size 36
Population Veterans at high suicide risk with baseline opioid misuse
Intervention enhanced treatment as usual (eTAU)
Duration 12-month follow-up
Topics Meditation
Keywords Veterans Opioid misuse
Key findings Among high suicide risk Veterans who misused opioids, adding MBCT-S to enhanced treatment as usual was associated with lower relative risk of suicide attempt (17%) and acute psychiatric hospitalization (42%) over 12 months, and more than halved rates of opioid misuse during follow-up, though only the hospitalization difference was statistically significant. The authors conclude that a larger trial is warranted.

Abstract

Knowledge of how to effectively prevent suicide attempt (SA) in high suicide risk patients who also misuse opioids is limited. In a subset of data from 36 participants with baseline opioid misuse in a randomized clinical trial testing adjunctive Mindfulness-Based Cognitive Therapy to prevent suicide among high suicide risk Veterans (n=18 per treatment condition), MBCT-S reduced the likelihood of SA and acute psychiatric hospitalization over 12-months follow-up. Those in MBCT-S had a relative risk of 17% and 42% for SA and hospitalization (p=.09, .02), respectively, compared to those receiving enhanced treatment as usual (eTAU) alone. Rates of opioid misuse during follow-up were more than halved with the addition of MBCT-S to eTAU (p=.08). Meanwhile, among trial participants who did not misuse opioids (n=104), RRs of 64% and 77% for SA and hospitalization (p=.28, .33), respectively, were found with MBCT-S compared to eTAU. An MBCT-S trial with greater power is warranted in this population.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics